0001437749-23-007405.txt : 20230321 0001437749-23-007405.hdr.sgml : 20230321 20230321163946 ACCESSION NUMBER: 0001437749-23-007405 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230317 FILED AS OF DATE: 20230321 DATE AS OF CHANGE: 20230321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lindborg Stacy CENTRAL INDEX KEY: 0001813667 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15911 FILM NUMBER: 23750151 MAIL ADDRESS: STREET 1: C/O BRAINSTORM CELL THERAPEUTICS, INC. STREET 2: 1325 AVENUE OF AMERICAS, 28TH FLR. CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Imunon, Inc. CENTRAL INDEX KEY: 0000749647 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521256615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 997 LENOX DRIVE STREET 2: SUITE 100 CITY: LAWRENCEVILLE STATE: NJ ZIP: 08648 BUSINESS PHONE: (609) 896-9100 MAIL ADDRESS: STREET 1: 997 LENOX DRIVE STREET 2: SUITE 100 CITY: LAWRENCEVILLE STATE: NJ ZIP: 08648 FORMER COMPANY: FORMER CONFORMED NAME: Celsion CORP DATE OF NAME CHANGE: 20071121 FORMER COMPANY: FORMER CONFORMED NAME: CELSION CORP DATE OF NAME CHANGE: 19980515 FORMER COMPANY: FORMER CONFORMED NAME: CHEUNG LABORATORIES INC DATE OF NAME CHANGE: 19920703 4 1 rdgdoc.xml FORM 4 X0407 4 2023-03-17 0000749647 Imunon, Inc. IMNN 0001813667 Lindborg Stacy C/O IMUNON, INC. 997 LENOX DRIVE, SUITE 100 LAWRENCEVILLE NJ 08648 1 0 Stock Option (Right to Buy) 1.32 2023-03-17 4 A 0 2000 0 A 2023-03-17 2033-03-17 Common Stock 2000 9666 D Represents the closing price of Imunon, Inc. Common Stock on the date of grant. The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. /s/ Kimberly Bragg, VP of Finance & Controller 2023-03-21